Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Kyn Therapeutics and Merck begin Phase Ib/I trials of ARY-007

Micrograph of a colorectal villous adenoma. Credit: Nephron.

  • Kyn Therapeutics

Go Top